MOSCOW: The Russian Direct Investment Fund (RDIF) has announced the approval of the Russian single-dose Sputnik Light coronavirus vaccine in Kazakhstan.
"The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of Kazakhstan," the RDIF said in a statement.
According to the RDIF, Kazakhstan approved the two-dose Sputnik V vaccine and launched its production at the Karaganda pharmaceutical complex following a transfer of technology from the RDIF and the Gamaleya Center in February 2021.
Sputnik Light is the first component of Sputnik V. "Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered," the RDIF said.
Sputnik V has been authorized in 67 countries with an overall population of more than 3.5 billion people.